BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12765477)

  • 1. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
    Gregorio GV; McFarlane B; Bracken P; Vergani D; Mieli-Vergani G
    Autoimmunity; 2002 Dec; 35(8):515-9. PubMed ID: 12765477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
    Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
    Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune paediatric liver disease.
    Mieli-Vergani G; Vergani D
    World J Gastroenterol; 2008 Jun; 14(21):3360-7. PubMed ID: 18528933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune liver disease in children.
    Mieli-Vergani G; Vergani D
    Ann Acad Med Singap; 2003 Mar; 32(2):239-43. PubMed ID: 12772529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.
    Amin K; Rasool AH; Hattem A; Al-Karboly TA; Taher TE; Bystrom J
    World J Gastroenterol; 2017 Feb; 23(8):1345-1352. PubMed ID: 28293081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases.
    Villalta D; Mytilinaiou MG; Elsner M; Hentschel C; Cuccato J; Somma V; Schierack P; Roggenbuck D; Bogdanos DP
    Clin Chim Acta; 2015 Oct; 450():1-5. PubMed ID: 26220739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of autoantibodies in autoimmune hepatitis.
    Liberal R; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Oct; 46():17-24. PubMed ID: 24016388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile autoimmune hepatitis: A comprehensive review.
    Sokollik C; McLin VA; Vergani D; Terziroli Beretta-Piccoli B; Mieli-Vergani G
    J Autoimmun; 2018 Dec; 95():69-76. PubMed ID: 30344030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody Profile of Adult Patients With Childhood Onset Type 2 Autoimmune Hepatitis.
    Woynarowski M; Woźniak M; Cukrowska B; Wierzbicka A; Lytton SD
    J Clin Lab Anal; 2016 Sep; 30(5):590-6. PubMed ID: 26676069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis in children: what is different from adult AIH?
    Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune liver serology: current diagnostic and clinical challenges.
    Bogdanos DP; Invernizzi P; Mackay IR; Vergani D
    World J Gastroenterol; 2008 Jun; 14(21):3374-87. PubMed ID: 18528935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
    Zachou K; Rigopoulou E; Dalekos GN
    J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
    Han S; Tredger M; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1995 Jan; 21(1):58-62. PubMed ID: 7806169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case-control study in China.
    Wu J; Guo N; Zhu L; Zhang X; Xiong C; Liu J; Xu Y; Fan J; Yu J; Pan Q; Yang J; Liang H; Jin X; Ye S; Wang W; Liu C; Zhang J; Li G; Jiang B; Cao H; Li L
    Emerg Microbes Infect; 2020; 9(1):332-340. PubMed ID: 32037983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.
    Khayat A; Vitola B
    J Pediatr; 2021 Dec; 239():155-160. PubMed ID: 34454951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
    Dalekos GN; Zachou K; Liaskos C; Gatselis N
    Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of clinical and laboratory indexes in patients with liver disease with positive anti-liver cytosol antibody].
    Zhang HP; Yan HP; Lou JL; Huang CY; Ma YX; Li LJ; Han Y; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Dec; 29(12):1182-1187. PubMed ID: 35045634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.